Successfully introducing new drugs and therapies in a quicker and more cost-effective manner starts in the most complex phase on of drug development; the clinical phase. The implementation of risk-based monitoring increases the overall quality of data while providing better oversight of patient safety. With the introduction of centralized monitoring in a risk-based monitoring approach, pharmaceutical companies are able to embrace a real-time overview of data and risk detection.
The
Central Monitoring Summit will arm delegates with the tools they need to optimize existing clinical operation platforms and build quality into the design for a sound central monitoring foundation. Join your colleagues and our expert speaking staff as they provide in-depth insights into shifting your monitoring processes from an excessive concentration of data to risk-driven monitoring that uses central monitoring and technology enablement.
Special Focus
- Discuss Case Studies and Practical Solutions Across Pharma on the Successful Implementation of Centralized Monitoring
- Adopt Change Management and Infrastructure Changes Needed in Adoption of Central and Remote Monitoring Practices
- Fine-Tune Responsibilities or Job Description of the Central Monitor
- Use Predictive Analysis for a Central CRA or Study Manager to Understand the Trends in Clinical Data and to See Critical Development Earlier
''While I'm 10+ years in the industry (18 months in Quality), I learned a lot! Great networking.''
Senior Clinical Quality Manager, NOVARTIS
''Discussions, presentations, interactions have provided a clear picture of common issues.''
VP Quality, ALTASCIENCES
''I was able to find weaknesses in my process that I will need to review.''
Director, CQA, TREVENA
"Members could share struggles, challenges, and ideas. It was also a good forum to build my network. As the conference went on, people seemed to share more lessons learned, shared learning, and tip/tricks. I liked this. It's more helpful to share challenges that are followed by solutions.'"
Associate Director, Quality Systems, VERTEX
Speakers
- Joanne Benedict, M.Sc., Senior Advisor, ROCHE
- Lisa Berdan, Director, Global Megatrials, DUKE CLINICAL RESEARCH INSTITUTE
- David Bocobo, Senior Central Monitor – Risk Based Monitoring, BRISTOL-MYERS SQUIBB
- Sina Djali, Head of Risk Management – Central Monitoring Integrated Data Analytics and Reporting Global Clinical Development Operations, JANSSEN R&D
- Oksana Gecha, Head of Central Monitoring Global Data Strategies and Solutions (GDSS), BRISTOL-MYERS SQUIBB
- Jennessa Martin, Regulatory Affairs Coordinator, FIBROCELL SCIENCE
- Jaylaxmi Nalawade, Senior Manager – Drug Safety and Risk Management, LUPIN LIMITED
- Kimberly Nessel, Director, Clinical Scientist CVM, THE JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
- Morten Thorup Pedersen, Risk-Based Monitoring Specialist, NOVO NORDISK A/S
- Elizabeth Robinson, RN, MSHS, Executive Director, Clinical Compliance and Operations, HORIZON PHARMA
- Anne M. Smith, Consultant, Central Monitoring, ELI LILLY AND COMPANY
- Steve Young, Chief Operations Officer, CLUEPOINTS
Please fill in your name and email to receive the conference agenda of this event.
Conference Day One - Thursday, March 22, 2017
Conference Day Two - Frday, March 23, 2017
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Who Should Attend
This conference is designed for Life Sciences representatives with responsibilities in:
- Monitoring
- Medical Review
- Clinical Data/Trial Management
- Trial Innovation/Design
- Biostatistics
- Quality Management
- Clinical Research Associates (CRAs)
- Drug Safety
SECONDARY MARKET
The conference will benefit monitoring supplier groups, including:
- CROs
- Risk-Based Monitoring Vendors
- Electronic Data Capture (EDC)
- Clinical Analytics
Venue
Wyndham Philadelphia Historic District400 Arch Street
Philadelphia, PA 19106
Simply the best of both worlds. Just one block off Market Street and within walking distance of popular landmarks, including Independence National Park, Liberty Bell Center, Independence Hall, and Betsy Ross House. We’re also minutes away from the Philadelphia Convention Center, Art Museum, the Barnes Foundation, Franklin Institute, Rittenhouse Square, Penn’s Landing, and the Central Business District.
To make reservations, guests can call 1-877-999-3223 and request the group rate for ExL’s March Meetings.
To make reservations online: Click Here
The group rate is available until February 28, 2018. Please book your room early, as rooms available at this rate are limited.
